FATE · Fate Therapeutics Inc · Documents
Market Cap
$250.42M
Shares
119.82M
Volume · Oct 22
865.6K
Avg daily vol (3M)
1.6M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-12-22 | 2020-12-17 | |
| 8-K | — | 2020-12-07 | 2020-12-04 | |
| 8-K | — | 2020-11-05 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-08-19 | 2020-08-17 | |
| 8-K | — | 2020-08-05 | — | |
| 10-Q | — | 2020-08-05 | 2020-06-30 | |
| 8-K | — | 2020-06-10 | 2020-06-08 | |
| 10-Q | — | 2020-05-11 | 2020-03-31 | |
| 8-K | — | 2020-05-11 | — | |
| 8-K | — | 2020-05-05 | 2020-05-01 | |
| 8-K | — | 2020-04-28 | 2020-04-17 | |
| 8-K | — | 2020-04-02 | — | |
| DEF 14A | — | 2020-03-20 | 2020-05-01 | |
| DEFA14A | — | 2020-03-20 | — | |
| 10-K | — | 2020-03-02 | 2019-12-31 | |
| 8-K | — | 2020-03-02 | — | |
| 8-K | — | 2020-01-10 | 2020-01-07 |
Showing 101–118 of 118 filings
Key facts
CIK
1434316
CUSIP
31189P102
13F (30d)
14 filings
14 filers
Visit website
Investor relations